Suppr超能文献

增殖细胞核抗原分级在恶性黑色素瘤中的预后意义。

Prognostic significance of PCNA grade in malignant melanoma.

作者信息

Woosley J T, Dietrich D R

机构信息

Department of Pathology, University of North Carolina School of Medicine, Chapel Hill 27514.

出版信息

J Cutan Pathol. 1993 Dec;20(6):498-503. doi: 10.1111/j.1600-0560.1993.tb00677.x.

Abstract

Proliferating cell nuclear antigen (PCNA) grade (a semi-quantitative assessment of the entire tumor profile) and estimation whether PCNA grade is low (0-50% positive cells) or high (51-100% positive cells) has been demonstrated to be of prognostic significance in gastric carcinoma. Sixteen vertical growth phase melanomas with 8 or more years of clinical follow-up were reacted with antibody to PCNA. PCNA grade was independently evaluated by both authors without knowledge of clinical outcome. PCNA grade was subsequently correlated with clinical outcome and other prognostic indicators. Agreement in assigning PCNA grade was noted between the two observers in 13/16 cases. However, PCNA grade failed to accurately predict patient survival or death. Additionally, PCNA grade was not significantly correlated with other recognized prognostic attributes. While interpretation of the prognostic significance of PCNA grade based upon this small series of cases should be conservative, a semi-quantitative estimate of PCNA-positive cells appears to have little utility in predicting the clinical outcome in malignant melanoma.

摘要

增殖细胞核抗原(PCNA)分级(对整个肿瘤特征的半定量评估)以及评估PCNA分级是低(阳性细胞占0 - 50%)还是高(阳性细胞占51 - 100%),已被证明在胃癌中具有预后意义。对16例处于垂直生长期且有8年或更长时间临床随访的黑色素瘤进行PCNA抗体反应。两位作者在不知道临床结果的情况下独立评估PCNA分级。随后将PCNA分级与临床结果及其他预后指标进行关联。两位观察者在16例中的13例对PCNA分级的判定意见一致。然而,PCNA分级未能准确预测患者的生存或死亡。此外,PCNA分级与其他公认的预后属性无显著相关性。虽然基于这一小系列病例对PCNA分级预后意义的解释应保守,但PCNA阳性细胞的半定量估计在预测恶性黑色素瘤的临床结果方面似乎效用不大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验